Astellas Pharma Inc. has successfully completed the acquisition of Propella Therapeutics, Inc., making Propella a wholly-owned subsidiary of Astellas as of December 21, 2023. The acquisition incl...
Astellas Pharma Inc. and Propella Therapeutics, Inc. have entered into a merger agreement, marking a significant development in the field of digital wealth management. Through its U.S. subsidiary...
